Acute anthracycline cardiotoxicity. Comparative morphologic study of three analogues

Area of Science:

• Cardiovascular Toxicology
• Cancer Chemotherapy
• Pharmacology

Background:

• Anthracycline antibiotics are effective chemotherapeutics but their use is limited by dose-dependent cardiotoxicity.
• Developing anthracycline analogues with reduced cardiac toxicity is a critical goal in cancer treatment.

Purpose of the Study:

• To compare the early ultrastructural effects of Adriamycin (doxorubicin) and three purported less cardiotoxic anthracycline analogues on rabbit myocytes.
• To investigate if these analogues induce distinctive nuclear alterations compared to other DNA-interactive agents.

Main Methods:

• Isolated perfused rabbit heart model.
• Perfusion with Adriamycin, daunomycin, aclacinomycin, rubidazone, cyclophosphamide congeners (phosphoramide mustard, 4-hydroperoxy cyclophosphamide), or dactinomycin.
• Electron microscopic examination of myocyte ultrastructure.

Main Results:

• All four anthracyclines induced a distinctive clumping of nuclear chromatin.
• No such nuclear changes were observed with cyclophosphamide congeners or dactinomycin.
• The nuclear alterations caused by the anthracycline analogues were indistinguishable from each other.

Conclusions:

• The studied anthracycline analogues produce acute, distinctive nuclear alterations in myocytes.
• These nuclear changes are unique compared to other DNA-interactive chemotherapeutic agents.
• Further research is needed to correlate these early nuclear changes with late-onset cardiotoxicity.